Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYTOKINETICS INCCYTK · Entity 3528 | Chief HR & Admin Officer | March 07, 2022 | March 08, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYTOKINETICS INC
Report date March 07, 2022 · Filed March 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 153,233 |
Reported balance
After 2022-03-07 transaction · row 1
1 source rowRow 1 · 2022-03-07 · Tax withholding · Disposed 5,399 · Balance 153,233 F1: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/07/2022 and does not represent a sale by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/07/2022 and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 33,889 | $7.14 Strike: $7.14 | $241,967.46 |
DisclosureSEC source: 0001061983-19-000022 · edgardoc.xml · derivative · entry 3 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,889 Underlying: Common Stock · 33,889 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 16,111 | $7.14 Strike: $7.14 | $115,032.54 |
DisclosureSEC source: 0001061983-19-000022 · edgardoc.xml · derivative · entry 2 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,111 Underlying: Common Stock · 16,111 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-19-000022 · edgardoc.xml · nonDerivative · entry 1 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,783 F1 · deemedExecutionDate: This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 2,730 | $7.75 | $21,157.50 |
DisclosureSEC source: 0001061983-18-000014 · edgardoc.xml · nonDerivative · entry 4 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,865 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 5,741 | $7.75 | $44,492.75 |
DisclosureSEC source: 0001061983-18-000014 · edgardoc.xml · nonDerivative · entry 3 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,595 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 15,000 | $0.00 | $15.00 |
DisclosureSEC source: 0001061983-18-000014 · edgardoc.xml · nonDerivative · entry 2 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,336 Read SEC document |
| February 27, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 24,268 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-18-000014 · edgardoc.xml · derivative · entry 6 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,268 Underlying: Common Stock · 24,268 shares Expires 2028-02-27 F2 · derivative.exercise_date: When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022. Read SEC document |
| February 27, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 15,732 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-18-000014 · edgardoc.xml · derivative · entry 5 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,732 Underlying: Common Stock · 15,732 shares Expires 2028-02-27 F2 · derivative.exercise_date: When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022. Read SEC document |
| February 27, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 30,000 | $0.00 | $30.00 |
DisclosureSEC source: 0001061983-18-000014 · edgardoc.xml · nonDerivative · entry 1 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,336 F1 · balance_after: The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/27/2019, 40% on 02/27/2020 and 20% on 03/01/2021. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:05 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,166 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-17-000014 · edgardoc.xml · derivative · entry 5 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,166 Underlying: Common Stock · 14,166 shares Expires 2027-02-28 F2 · derivative.exercise_date: When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:05 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 5,834 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-17-000014 · edgardoc.xml · derivative · entry 4 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2027-02-28 F2 · derivative.exercise_date: When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:05 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 20,000 | $0.00 | $20.00 |
DisclosureSEC source: 0001061983-17-000014 · edgardoc.xml · nonDerivative · entry 3 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,018 F1 · balance_after: The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/28/2018, 40% on 02/28/2019 and 20% on 02/28/2020. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:05 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 6,008 | $10.60 | $63,684.80 |
DisclosureSEC source: 0001061983-17-000014 · edgardoc.xml · nonDerivative · entry 2 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,018 Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:05 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 15,000 | $0.00 | $15.00 |
DisclosureSEC source: 0001061983-17-000014 · edgardoc.xml · nonDerivative · entry 1 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,026 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.